清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Abstract P1-16-07: A synthetic lethality treatment strategy for p53 mutant breast cancer

合成致死 癌症研究 癌症 突变体 乳腺癌 癌细胞 聚ADP核糖聚合酶 医学 生物 内科学 聚合酶 DNA 遗传学 基因
作者
Andrei V. Bakin,Justin Zonneville,Moyi Wang,Mohammed Alruwaili,Kevin H. Eng,Renuka Iyer,Ben Park,Christos Fountzilas
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:82 (4_Supplement): P1-07
标识
DOI:10.1158/1538-7445.sabcs21-p1-16-07
摘要

Abstract Breast carcinomas commonly carry mutations in the tumor suppressor p53, while therapeutic efforts to target mutant p53 were largely unfruitful. Here we report preclinical data supporting a novel combination therapy strategy for treatment of p53-mutant cancers. Genomic data revealed a high expression activity of Base-Excision Repair (BER) pathways in p53-mutant breast cancers. We designed a new methodology for testing BER in live cells. The BER studies revealed a significant dysregulation in BER-mediated repair in p53-mutant cancer cells. Taken advantage in the BER defect, we developed a novel treatment strategy that specifically targets p53-mt cancers. We found that treatment with deoxyuridine analogues induced accumulation of DNA damage selectively in p53-mutant cells. Further, inhibitors of poly (ADP-ribose) polymerase (PARPi) greatly enhanced this response and increased cell death, although PARPi as a single agent was not effective. In contrast, normal cells responded to PARPi with activation of the p53-p21 axis and cell cycle arrest. Inactivation of p53 in p53 wild-type cell lines conferred the p53-mutant phenotype. Preclinical breast cancer studies revealed that the combination of deoxyuridine analogue with PARPi was more effective in inhibition of tumor growth and metastases than either drug alone. This work illustrates a novel combination therapy strategy that may improve survival rates and outcomes for thousands of breast cancer patients. Citation Format: Andrei Bakin, Justin Zonneville, Moyi Wang, Mohammed Alruwaili, Kevin Eng, Renuka Iyer, Ben Park, Christos Fountzilas. A synthetic lethality treatment strategy for p53 mutant breast cancer [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P1-16-07.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
14秒前
KINGAZX完成签到 ,获得积分10
22秒前
今今完成签到 ,获得积分10
25秒前
CodeCraft应助赫123采纳,获得10
28秒前
斯文败类应助科研通管家采纳,获得10
30秒前
Kao应助科研通管家采纳,获得10
30秒前
Kao应助科研通管家采纳,获得10
30秒前
32秒前
Evan完成签到,获得积分10
32秒前
YifanWang应助Evan采纳,获得30
36秒前
1分钟前
1分钟前
1分钟前
赫123发布了新的文献求助10
1分钟前
vitamin完成签到 ,获得积分0
1分钟前
今后应助赫123采纳,获得10
1分钟前
zhangjianing发布了新的文献求助10
1分钟前
2分钟前
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
2分钟前
银河里完成签到 ,获得积分10
2分钟前
FashionBoy应助水寒风似刀采纳,获得10
3分钟前
3分钟前
斯文败类应助笑点低冥采纳,获得10
3分钟前
3分钟前
3分钟前
3分钟前
笨笨完成签到 ,获得积分10
3分钟前
赫123发布了新的文献求助10
3分钟前
3分钟前
3分钟前
3分钟前
3分钟前
一方完成签到,获得积分10
4分钟前
土豪的糜应助水寒风似刀采纳,获得10
4分钟前
4分钟前
玛琳卡迪马完成签到,获得积分10
4分钟前
烟花应助科研通管家采纳,获得10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Nondestructive Testing Handbook: Vol. 4, Thermal and Infrared Testing (IR), 4th ed 800
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 590
Évora na Idade Média 555
Soil mites of the family Rhagidiidae (Actinedida: Eupodoidea). Morphology, Systematics, Ecology 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Radical Reactions 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7355108
求助须知:如何正确求助?哪些是违规求助? 8965987
关于积分的说明 19048412
捐赠科研通 7003057
什么是DOI,文献DOI怎么找? 3222075
关于科研通互助平台的介绍 2386301
邀请新用户注册赠送积分活动 2202691